Back to results
US 5,516,887 AGranted
Luteinizing hormone releasing hormone antagonist peptides
AssigneeRomano Deghenghi
InventorRomano Deghenghi
Life of this patent
Estimating the term…
Abstract
A luteinizing hormone releasing hormone antagonist peptide is provided which effectively decreases plasma levels of estrogens and androgens. The peptide exhibits increased levels of potency while at the same time minimizing histamine releasing properties, vascular permeability (or edematogenic effects), hypotension, poor water solubility an inadequate duration of action associated with luteinizing hormone releasing hormone antagonist peptides of the past.
Claims3
A luteinizing hormone releasing hormone antagonist peptide whose structure is SEQ ID NO.:
- 1 wherein the Alanine residue at SEQUENCE position 1 is N-acetyl-D-3-(2-naphthyl)-Ala;
- the Phenylalanine residue at SEQUENCE position 2 is D-3-(4-chlorophenyl) alanine;
- the Alanine residue at SEQUENCE position 3 is D-3(3-pyridyl)-Ala;
- the Lysine residue at SEQUENCE position 6 is D-6-carbamoyl lysine;
- the Lysine residue at SEQUENCE position number 8 is N.epsilon.-isopropyl-Lys;
- and the Alanine residue at SEQUENCE position 10 is D-Ala-NH.sub.2.
3 more elements
Dependencies are inferred from the claim text.